RU2015131801A - GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM - Google Patents

GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM Download PDF

Info

Publication number
RU2015131801A
RU2015131801A RU2015131801A RU2015131801A RU2015131801A RU 2015131801 A RU2015131801 A RU 2015131801A RU 2015131801 A RU2015131801 A RU 2015131801A RU 2015131801 A RU2015131801 A RU 2015131801A RU 2015131801 A RU2015131801 A RU 2015131801A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
pharmaceutically acceptable
respiratory tract
upper respiratory
glutarimid
Prior art date
Application number
RU2015131801A
Other languages
Russian (ru)
Other versions
RU2610274C2 (en
RU2610274C3 (en
Inventor
Владимир Евгеньевич Небольсин
Татьяна Александровна Кромова
Галина Александровна Желтухина
Original Assignee
Общество С Ограниченной Ответственностью "Фарминтерпрайсез"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Фарминтерпрайсез" filed Critical Общество С Ограниченной Ответственностью "Фарминтерпрайсез"
Priority to RU2015131801A priority Critical patent/RU2610274C3/en
Priority claimed from RU2015131801A external-priority patent/RU2610274C3/en
Publication of RU2015131801A publication Critical patent/RU2015131801A/en
Publication of RU2610274C2 publication Critical patent/RU2610274C2/en
Application granted granted Critical
Publication of RU2610274C3 publication Critical patent/RU2610274C3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (11)

1. Соединение формулы:1. The compound of the formula:
Figure 00000001
Figure 00000001
 или его фармацевтически приемлемая соль.or a pharmaceutically acceptable salt thereof. 2. Лекарственное средство для лечения заболеваний верхних дыхательных путей, представляющее собой соединение по п.1 или его фармацевтически приемлемую соль.2. A drug for the treatment of diseases of the upper respiratory tract, which is a compound according to claim 1 or its pharmaceutically acceptable salt. 3. Лекарственное средство по п.2, где заболевание верхних дыхательных путей представляет собой риносинусит.3. The drug according to claim 2, where the disease of the upper respiratory tract is rhinosinusitis. 4. Фармацевтическая композиция для лечения заболеваний верхних дыхательных путей, включающая эффективное количество соединения по п.1 или его фармацевтически приемлемой соли, и фармацевтически приемлемые наполнители.4. A pharmaceutical composition for treating diseases of the upper respiratory tract, comprising an effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt thereof, and pharmaceutically acceptable excipients. 5. Фармацевтическая композиция по п.4, где заболевание верхних дыхательных путей представляет собой риносинусит.5. The pharmaceutical composition according to claim 4, where the upper respiratory tract disease is rhinosinusitis. 6. Способ лечения заболеваний верхних дыхательных путей, включающий введение пациенту эффективного количества соединения по п.1 или его фармацевтически приемлемой соли.6. A method of treating diseases of the upper respiratory tract, comprising administering to the patient an effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt thereof. 7. Способ по п. 6, где заболевание представляет собой риносинусит.7. The method of claim 6, wherein the disease is rhinosinusitis. 8. Применение соединения по п.1 или его фармацевтически приемлемой соли для получения лекарственного средства для лечения заболеваний верхних дыхательных путей.8. The use of a compound according to claim 1 or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of diseases of the upper respiratory tract. 9. Применение по п.8, где заболевание представляет собой риносинусит.9. The use of claim 8, where the disease is rhinosinusitis.
RU2015131801A 2015-07-30 GLUTARIMIDE DERIVATIVE, ITS APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON IT, METHOD FOR ITS OBTAINING RU2610274C3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015131801A RU2610274C3 (en) 2015-07-30 GLUTARIMIDE DERIVATIVE, ITS APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON IT, METHOD FOR ITS OBTAINING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015131801A RU2610274C3 (en) 2015-07-30 GLUTARIMIDE DERIVATIVE, ITS APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON IT, METHOD FOR ITS OBTAINING

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2013116826A Division RU2562773C3 (en) 2013-04-12 2013-04-12 GLUTARIMIDE DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS OF THEIR PRODUCTION

Publications (3)

Publication Number Publication Date
RU2015131801A true RU2015131801A (en) 2017-02-03
RU2610274C2 RU2610274C2 (en) 2017-02-08
RU2610274C3 RU2610274C3 (en) 2023-12-21

Family

ID=

Also Published As

Publication number Publication date
RU2610274C2 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
RU2018110647A (en) Aryl, heteroaryl and heterocyclic compounds for the treatment of diseases
JP2018109022A5 (en)
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
SA520411119B1 (en) Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof
JP2018513107A5 (en)
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
RU2016105581A (en) METHOD FOR TREATING ACUTE, CHRONIC AND SIMPLE COUGH AND IRREGULAR DESIRE
RU2017105353A (en) COMPOUNDS
JP2016510326A5 (en)
EA201270144A1 (en) COMBINED THERAPY FOR TREATMENT OF DIABETES
RU2015134581A (en) NITROXIL DONORS WITH IMPROVED THERAPEUTIC INDEX
EA201492010A1 (en) APPLICATION OF HIGH DOSE OF LACHINIMODE FOR TREATMENT OF MULTIPLE SCLEROSIS
RU2013150861A (en) PHARMACEUTICAL COMPOSITION CONTAINING GLUTARIMIDE DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF EOSINOPHILIC DISEASES
EA032951B1 (en) Glutarimide derivative, use thereof, pharmaceutical composition based thereon, process for preparing same
JP2015522018A5 (en)
JP2016522254A5 (en)
RU2014141893A (en) APPLICATION OF THE PYRAZOLE DERIVATIVE IN THE TREATMENT OF ACUTE ACTIONS OF CHRONIC OBSTRUCTIVE LUNG DISEASE
JP2015516419A5 (en)
WO2018005801A3 (en) Novel non-systemic tgr5 agonists
RU2016112257A (en) COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND / OR FIBROSIS
RU2012137245A (en) READING INDUCTOR AND THERAPEUTIC AGENT FOR GENETIC DISEASES CAUSED BY MUTATIONS OF THE TYPE OF NONSENS MUTATIONS
EA201792565A1 (en) BISAMID DERIVATIVE OF DICARBONIC ACID AS A MEANS STIMULATING TISSUE REGENERATION AND RESTORING DECREASED TISSUE FUNCTIONS
RU2020120876A (en) A PHARMACEUTICAL COMPOSITION CONTAINING ANTAGONIST OF MINERALOCORTICOID RECEPTORS AND ITS APPLICATION
RU2015131803A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM
RU2013107659A (en) KASEINKINASE INHIBITOR 1δ AND KASEINKINASE 1ε

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20190115

Effective date: 20190115

QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20190220

Effective date: 20190220

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20190115

Effective date: 20200914

PC41 Official registration of the transfer of exclusive right

Effective date: 20201103